Findlay Park Partners Llp Lowers stake in AmerisourceBergen Corp. (ABC)

AmerisourceBergen Corp. (ABC) : Findlay Park Partners Llp reduced its stake in AmerisourceBergen Corp. by 5.11% during the most recent quarter end. The investment management company now holds a total of 2,135,000 shares of AmerisourceBergen Corp. which is valued at $189,822,850 after selling 115,038 shares in AmerisourceBergen Corp. , the firm said in a disclosure report filed with the SEC on Aug 10, 2016.AmerisourceBergen Corp. makes up approximately 2.09% of Findlay Park Partners Llp’s portfolio.

Other Hedge Funds, Including , Palisade Capital Managementnj boosted its stake in ABC in the latest quarter, The investment management firm added 586 additional shares and now holds a total of 3,781 shares of AmerisourceBergen Corp. which is valued at $339,874. AmerisourceBergen Corp. makes up approx 0.01% of Palisade Capital Managementnj’s portfolio.Emerald Advisers Incpa boosted its stake in ABC in the latest quarter, The investment management firm added 34,400 additional shares and now holds a total of 46,730 shares of AmerisourceBergen Corp. which is valued at $3,980,929. AmerisourceBergen Corp. makes up approx 0.18% of Emerald Advisers Incpa’s portfolio. Goelzer Investment Management added ABC to its portfolio by purchasing 16,800 company shares during the most recent quarter which is valued at $1,442,448. AmerisourceBergen Corp. makes up approx 0.19% of Goelzer Investment Management’s portfolio.

AmerisourceBergen Corp. closed down -0.12 points or -0.13% at $88.85 with 20,89,408 shares getting traded on Friday. Post opening the session at $88.53, the shares hit an intraday low of $88.26 and an intraday high of $89 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, AmerisourceBergen Corp. reported $1.37 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.27. The company had revenue of $36900.00 million for the quarter, compared to analysts expectations of $36705.18 million. The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.20 EPS.

Many Wall Street Analysts have commented on AmerisourceBergen Corp.. Company shares were Reiterated by Mizuho on Aug 11, 2016 to “Neutral”, Firm has raised the Price Target to $ 90 from a previous price target of $80 .Company shares were Reiterated by FBR Capital on Aug 3, 2016 to “Mkt Perform”, Firm has raised the Price Target to $ 90 from a previous price target of $84 .Company shares were Reiterated by Barclays on Aug 3, 2016 to “Equal Weight”, Firm has raised the Price Target to $ 89 from a previous price target of $83 .

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally the Company offers healthcare providers and pharmaceutical manufacturers with services including reimbursement and pharmaceutical consulting services logistics services inventory management pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.

Leave a Reply

AmerisourceBergen Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on AmerisourceBergen Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.